Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 14, 2019; 25(34): 5105-5119
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5105
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5105
Figure 1 Histopathological examination by hematoxylin-eosin staining (200×).
A: Control group; B: Model group; C: Pioglitazone hydrochloride group; D: Chinese herbal medicine group.
Figure 2 Histopathological examination by Oil red O staining (200×).
A: Control group; B: Model group; C: Pioglitazone hydrochloride group; D: Chinese herbal medicine group.
Figure 3 Masson’s trichrome staining of liver tissue sections (200×).
A: Control group; B: Model group; C: Pioglitazone hydrochloride group; D: Chinese herbal medicine group.
Figure 4 Occludin and Zonula occludens-1 protein expression in intestine determined by Western blot using β-actin as a reference protein.
- Citation: Yang JM, Sun Y, Wang M, Zhang XL, Zhang SJ, Gao YS, Chen L, Wu MY, Zhou L, Zhou YM, Wang Y, Zheng FJ, Li YH. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(34): 5105-5119
- URL: https://www.wjgnet.com/1007-9327/full/v25/i34/5105.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i34.5105